Article info

Download PDFPDF
One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD

Authors

  1. Correspondence to Dr Jennifer I Lim, 1855 W. Taylor St, Mail Code 648, Chicago, IL 60612, USA; jennylim{at}uic.edu
View Full Text

Citation

Lim JI, Niec M, Wong V
One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD

Publication history

  • Received August 15, 2014
  • Revised October 12, 2014
  • Accepted October 16, 2014
  • First published November 6, 2014.
Online issue publication 
April 17, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.